<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Troglitazone</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Troglitazone">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Troglitazone</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Troglitazone</b> is an antidiabetic and anti-inflammatory drug, and a member of the drug class of the <a href="Thiazolidinedione.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiazolidinedione" title="Thiazolidinedione">thiazolidinediones</a>. It was prescribed for people with diabetes mellitus type 2.<span class="mw-ref" id="cite_ref-NYT_1-0"><a href="#cite_note-NYT-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>  


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Troglitazone</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Troglitazone.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Troglitazone.svg.png" data-file-width="512" data-file-height="290" data-file-type="drawing" height="136" width="240"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Rezulin, Resulin, Romozin, Noscal</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>B (No risk in non-human studies)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth (tablets)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>A10BG01<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=A10BG01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=A10BG01'" tppabs="https://www.whocc.no/atc_ddd_index/?code=A10BG01" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li>Production and promotion ceased</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>16–34 hours</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(<i>RS</i>)-5-(4-[(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]benzyl)thiazolidine-2,4-dione</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=97322-87-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=97322-87-7'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=97322-87-7" class="external text external">97322-87-7</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5591  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5591'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5591" class="external text external">5591</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2693  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2693'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2693" class="external text external">2693</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00197  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00197'" tppabs="https://www.drugbank.ca/drugs/DB00197" class="external text external">DB00197</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.5389.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.5389.html'" tppabs="http://www.chemspider.com/Chemical-Structure.5389.html" class="external text external">5389</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=I66ZZ0ZN0E  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=I66ZZ0ZN0E'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=I66ZZ0ZN0E" class="external text external">I66ZZ0ZN0E</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00395  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00395'" tppabs="https://www.kegg.jp/entry/D00395" class="external text external">D00395</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9753  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9753'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9753" class="external text external">CHEBI:9753</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL408  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL408'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL408" class="external text external">ChEMBL408</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID8023719  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID8023719'" tppabs="https://comptox.epa.gov/dashboard/DTXSID8023719" class="external text external">DTXSID8023719</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>24</sub><span>H</span><sub>27</sub><span>N</span><span>O</span><sub>5</sub><span>S</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">441.54</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC1NC%28%3DO%29SC1Cc4ccc%28OCC3%28Oc2c%28c%28c%28O%29c%28c2CC3%29C%29C%29C%29C%29cc4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC1NC%28%3DO%29SC1Cc4ccc%28OCC3%28Oc2c%28c%28c%28O%29c%28c2CC3%29C%29C%29C%29C%29cc4'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC1NC%28%3DO%29SC1Cc4ccc%28OCC3%28Oc2c%28c%28c%28O%29c%28c2CC3%29C%29C%29C%29C%29cc4" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>184 to 186<span>&nbsp;</span>°C (363 to 367<span>&nbsp;</span>°F)</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C1NC(=O)SC1Cc4ccc(OCC3(Oc2c(c(c(O)c(c2CC3)C)C)C)C)cc4</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:GXPHKUHSUJUWKP-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470617744&page2=Troglitazone  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470617744&page2=Troglitazone'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470617744&page2=Troglitazone" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>It was patented in 1983 and approved for medical use in 1997.<span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It was subsequently withdrawn.</p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    
<p>Troglitazone, like the other <a href="Thiazolidinedione.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiazolidinedione" title="Thiazolidinedione">thiazolidinediones</a> (<a href="Pioglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pioglitazone" title="Pioglitazone">pioglitazone</a> and <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Rosiglitazone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Rosiglitazone'" tppabs="https://ptable.com/wiki/compounds/A/Rosiglitazone" title="Rosiglitazone">rosiglitazone</a>), works by activating peroxisome proliferator-activated receptors (PPARs).</p>

<p>Troglitazone is a ligand to both PPARα and – more strongly – PPARγ. Troglitazone also contains an α-tocopheroyl moiety, potentially giving it <a href="Vitamin_E.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_E" title="Vitamin E">vitamin E</a>-like activity in addition to its PPAR activation. It has been shown to reduce inflammation:<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> troglitazone use was associated with a decrease of nuclear factor kappa-B (NF-κB) and a concomitant increase in its inhibitor (IκB). NFκB is an important cellular transcription regulator for the immune response.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Rezulin.JPG" tppabs="https://ptable.com/wiki/compounds/I/m/Rezulin.JPG" data-file-width="2448" data-file-height="3264" data-file-type="bitmap" height="293" width="220"><div class="thumbcaption" style="text-align: left">A 30-tablet pharmacy stock bottle of Rezulin (troglitazone) (400 mg) from Parke-Davis. Manufactured 1997. Shown also is one broken tablet. Tablet branding is PD353.</div></div></div>
<p>It was developed by Daiichi Sankyo (Japan). In the United States, it was introduced and manufactured by Parke-Davis in the late 1990s, but turned out to be associated with an idiosyncratic reaction leading to drug-induced hepatitis. The F.D.A. medical officer assigned to evaluate troglitazone, John Gueriguian, did not recommend its approval due to potential high liver toxicity; Parke-Davis complained to the FDA and Gueriguian was subsequently removed from his post.<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> A panel of experts approved it in January 1997.<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span>  Once the prevalence of adverse liver effects became known, troglitazone was withdrawn from the British market in December 1997, from the United States market in 2000, and from the Japanese market soon afterwards. It did not get approval in the rest of Europe.</p>

<p>Troglitazone was developed as the first anti-diabetic drug having a mechanism of action involving the enhancement of insulin sensitivity.  At the time it was widely believed that such drugs, by addressing the primary metabolic defect associated with Type 2 diabetes, would have numerous benefits including avoiding the risk of hypoglycemia associated with insulin and earlier oral antidiabetic drugs.  It was further believed that reducing insulin resistance would potentially reduce the very high rate of cardiovascular disease that is associated with diabetes.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>

<p>Parke-Davis/Warner Lambert submitted the diabetes drug Rezulin for U.S. Food and Drug Administration (F.D.A.) review on July 31, 1996. The medical officer assigned to the review, Dr. John L. Gueriguian, cited Rezulin's potential to harm the liver and the heart and he questioned its viability in lowering blood sugar for patients with adult-onset diabetes, recommending against the drug's approval. After complaints from the drugmaker, Gueriguian was removed on November 4, 1996 and his review was purged by the F.D.A.<span class="mw-ref" id="cite_ref-LATimes_8-0"><a href="#cite_note-LATimes-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Willman_9-0"><a href="#cite_note-Willman-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Gueriguian and the company had a single meeting, at which Gueriguian used "intemperate" language; the company said its objections were based on inappropriate remarks made by Gueriguian.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Parke-Davis said at the advisory committee that the risk of liver toxicity was comparable to placebo and that additional data of other studies confirmed this.<span class="mw-ref" id="cite_ref-Avorn_11-0"><a href="#cite_note-Avorn-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span>  According to Peter Gøtzsche, when the company provided these additional data one week after approval, they showed a substantially greater risk for liver toxicity.<span class="mw-ref" id="cite_ref-gotzsche_12-0"><a href="#cite_note-gotzsche-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>The F.D.A. approved the drug on January 29, 1997, and it appeared in pharmacies in late March. At the time Dr. Solomon Sobel, a director at the F.D.A., overseeing diabetes drugs, said in a New York Times interview that adverse effects of troglitazone appeared to be rare and relatively mild.<span class="mw-ref" id="cite_ref-NYTapprove_13-0"><a href="#cite_note-NYTapprove-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>Glaxo Wellcome P.L.C. received approval from the British Medicines Control Agency (MCA) to market troglitazone, as Romozin, in July 1997.<span class="mw-ref" id="cite_ref-ICIS_14-0"><a href="#cite_note-ICIS-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> After reports of sudden liver failure in patients receiving the drug, the Parke-Davis and the FDA added warnings to the drug label requiring monthly monitoring of liver enzyme levels.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Glaxo removed troglitazone from the market in Britain on December 1, 1997.<span class="mw-ref" id="cite_ref-LATimes_8-1"><a href="#cite_note-LATimes-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> Glaxo had licensed the drug from Sankyo Company of Japan and had sold it in Britain from October 1, 1997.<span class="mw-ref" id="cite_ref-BBC_16-0"><a href="#cite_note-BBC-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-Fisher_17-0"><a href="#cite_note-Fisher-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<p>On May 17, 1998, a 55-year-old patient named Audrey LaRue Jones died of acute liver failure after taking troglitazone. Importantly, she had been monitored closely by physicians at the National Institutes of Health as a participant in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) diabetes prevention study.<span class="mw-ref" id="cite_ref-NIH_18-0"><a href="#cite_note-NIH-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-NEJM_19-0"><a href="#cite_note-NEJM-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> This called into question the efficacy of the monitoring strategy. The N.I.H. responded on June 4 by dropping troglitazone from the study.<span class="mw-ref" id="cite_ref-Willman_9-1"><a href="#cite_note-Willman-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-Gale_20-0"><a href="#cite_note-Gale-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Dr. David J. Graham, an F.D.A. epidemiologist charged with evaluating the drug, warned on March 26, 1999 of the dangers of using it and concluded that patient monitoring was not effective in protecting against liver failure. He estimated that the drug could be linked to over 430 liver failures and that patients incurred 1,200 times greater risk of liver failure when taking Rezulin.<span class="mw-ref" id="cite_ref-Willman_9-2"><a href="#cite_note-Willman-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-LATimes2_21-0"><a href="#cite_note-LATimes2-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Dr. Janet B. McGill, an endocrinologist who had assisted in the Warner–Lambert's early clinical testing of Rezulin, wrote in a March 1, 2000 letter to Sen. Edward M. Kennedy (D-Mass.): "I believe that the company . . . deliberately omitted reports of liver toxicity and misrepresented serious adverse events experienced by patients in their clinical studies."<span class="mw-ref" id="cite_ref-LATimes3_22-0"><a href="#cite_note-LATimes3-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>On March 21, 2000, the F.D.A. withdrew the drug from the market.<span class="mw-ref" id="cite_ref-FDAalert_23-0"><a href="#cite_note-FDAalert-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Dr. Robert I. Misbin, an F.D.A. medical officer, wrote in a March 3, 2000 letter to Senator John Ashcroft of strong evidence that Rezulin could not be used safely. He was later threatened by the FDA with dismissal. <span class="mw-ref" id="cite_ref-LATimes_8-2"><a href="#cite_note-LATimes-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span>  By that time the drug had been linked to 63 liver-failure deaths and had generated sales of more than $2.1 billion for Warner-Lambert.<span class="mw-ref" id="cite_ref-LATimes2_21-1"><a href="#cite_note-LATimes2-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> The drug cost $1,400 a year per patient in 1998.<span class="mw-ref" id="cite_ref-Fisher_17-1"><a href="#cite_note-Fisher-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Pfizer, which had acquired Warner-Lambert in February 2000, reported the withdrawal of Rezulin cost $136 million.<span class="mw-ref" id="cite_ref-Pfizer_25-0"><a href="#cite_note-Pfizer-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanisms_of_hepatotoxicity">Mechanisms of hepatotoxicity</h2></summary>
    
<p>Since the withdrawal in 2000, mechanisms of troglitazone hepatotoxicity have been extensively studied using a variety of in vivo,<span class="mw-ref" id="cite_ref-:0_26-0"><a href="#cite_note-:0-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> in vitro<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> and computational methods.<span class="mw-ref" id="cite_ref-:1_28-0"><a href="#cite_note-:1-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span>  These studies have suggested that hepatotoxicity of troglitazone results from a combination of nonmetabolic and metabolic factors.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span>  The nonmetabolic toxicity is a complex function of drug-protein interactions in the liver and biliary system.  Initially the metabolic toxicity was largely associated with reactive metabolite formation from the thiazolidinedione and chromane rings of troglitazone.  Moreover, the formation of quinone and o-quinone methide reactive metabolites were proposed to be formed by metabolic oxidation of the OH group of the chromane ring.<span class="mw-ref" id="cite_ref-:0_26-1"><a href="#cite_note-:0-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span>   Detailed quantum chemical analysis of the metabolic pathways for troglitazone has shown that quinone reactive metabolite is generated by oxidation of the OH group, but o-quinone methide reactive metabolite is formed by the oxidation of the methyl (CH<sub>3</sub>) groups ortho to the OH group of the chromane ring.<span class="mw-ref" id="cite_ref-:1_28-1"><a href="#cite_note-:1-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span>  This understanding has been recently used in the design of novel troglitazone derivatives with antiproliferative activity in breast cancer cell lines.<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Lawsuits">Lawsuits</h2></summary>
    
<p>In 2009 Pfizer Inc. resolved all but three of 35,000 claims over its withdrawn diabetes drug Rezulin for a total of about $750 million. Pfizer, which acquired rival Wyeth for almost $64 billion, paid about $500 million to settle Rezulin cases consolidated in federal court in New York, according to court filings. The company also paid as much as $250 million to resolve state-court suits. In 2004, it set aside $955 million to end Rezulin cases.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-NYT-1"> <span id="mw-reference-text-cite_note-NYT-1" class="mw-reference-text"><cite id="CITEREFFisher1997" class="citation news cs1">Fisher, Lawrence (4 November 1997). <a href="javascript:if(confirm('https://www.nytimes.com/1997/11/04/business/adverse-diabetes-drug-news-sends-warner-lambert-down.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1997/11/04/business/adverse-diabetes-drug-news-sends-warner-lambert-down.html'" tppabs="https://www.nytimes.com/1997/11/04/business/adverse-diabetes-drug-news-sends-warner-lambert-down.html" class="external text external">"Adverse Diabetes Drug News Sends Warner-Lambert Down"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 December</span> 2012</span>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Jnos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA450  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA450'" tppabs="https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA450" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>450. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite id="CITEREFAljadaGargGhanim2001" class="citation journal cs1">Aljada A, Garg R, Ghanim H,  et al. (2001). "Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action?". <i>J. Clin. Endocrinol. Metab</i>. <b>86</b> (7): 3250–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fjc.86.7.3250  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjc.86.7.3250'" tppabs="https://doi.org/10.1210%2Fjc.86.7.3250" class="external text external">10.1210/jc.86.7.3250</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11443197  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11443197'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11443197" class="external text external">11443197</a>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><a href="javascript:if(confirm('https://www.wired.com/medtech/drugs/multimedia/2008/10/gallery_retired_drugs?slide=6&slideView=6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wired.com/medtech/drugs/multimedia/2008/10/gallery_retired_drugs?slide=6&slideView=6'" tppabs="https://www.wired.com/medtech/drugs/multimedia/2008/10/gallery_retired_drugs?slide=6&slideView=6" class="external text external">Retired Drugs: Failed Blockbusters, Homicidal Tampering, Fatal Oversights</a>, wired.com</span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFCohen2006" class="citation journal cs1">Cohen, J. S. (2006). <a href="javascript:if(confirm('https://doi.org/10.1007/s00125-006-0245-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007/s00125-006-0245-0'" tppabs="https://doi.org/10.1007/s00125-006-0245-0" class="external text external">"Risks of troglitazone apparent before approval in USA"</a>. <i>Diabetologia</i>. <b>49</b> (6): 1454–5. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00125-006-0245-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00125-006-0245-0'" tppabs="https://doi.org/10.1007%2Fs00125-006-0245-0" class="external text external">10.1007/s00125-006-0245-0</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16601971  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16601971'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16601971" class="external text external">16601971</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFHenry_RR1996" class="citation journal cs1">Henry RR (September 1996). "Effects of troglitazone on insulin sensitivity". <i>Diabet. Med</i>. <b>13</b> (9 Suppl 6): S148–50. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8894499  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8894499'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8894499" class="external text external">8894499</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFKeen_H1994" class="citation journal cs1">Keen H (November 1994). "Insulin resistance and the prevention of diabetes mellitus". <i>N. Engl. J. Med</i>. <b>331</b> (18): 1226–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJM199411033311812  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJM199411033311812'" tppabs="https://doi.org/10.1056%2FNEJM199411033311812" class="external text external">10.1056/NEJM199411033311812</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7935664  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7935664'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7935664" class="external text external">7935664</a>.</cite></span></li><li id="cite_note-LATimes-8"> <span id="mw-reference-text-cite_note-LATimes-8" class="mw-reference-text"><cite id="CITEREFWillman2000" class="citation news cs1">Willman, David (20 December 2000). <a href="javascript:if(confirm('http://www.pulitzer.org/archives/6480  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pulitzer.org/archives/6480'" tppabs="http://www.pulitzer.org/archives/6480" class="external text external">"NEW FDA: Rezulin Fast-Track Approval and a Slow Withdrawal"</a>. <i>The Los Angeles Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 December</span> 2012</span>.</cite></span></li><li id="cite_note-Willman-9"> <span id="mw-reference-text-cite_note-Willman-9" class="mw-reference-text"><cite class="citation news cs1">Willman, David (4 June 2000). <a href="javascript:if(confirm('http://articles.latimes.com/2000/jun/04/news/mn-37375  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://articles.latimes.com/2000/jun/04/news/mn-37375'" tppabs="http://articles.latimes.com/2000/jun/04/news/mn-37375" class="external text external">"The Rise and Fall of the Killer Drug Rezulin"</a>. <i>The Los Angeles Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 December</span> 2012</span>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.apnewsarchive.com/1998/Report-FDA-Removes-Medical-Officer/id-76dfa040579fe2d4f72b9b8f9df981d6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.apnewsarchive.com/1998/Report-FDA-Removes-Medical-Officer/id-76dfa040579fe2d4f72b9b8f9df981d6'" tppabs="http://www.apnewsarchive.com/1998/Report-FDA-Removes-Medical-Officer/id-76dfa040579fe2d4f72b9b8f9df981d6" class="external text external">"Report: FDA Removes Medical Officer"</a>.</cite></span></li><li id="cite_note-Avorn-11"> <span id="mw-reference-text-cite_note-Avorn-11" class="mw-reference-text"><cite id="CITEREFAvorn2005" class="citation book cs1">Avorn, J (2005). <i>Powerful medicines</i>. New York: Vintage books.</cite></span></li><li id="cite_note-gotzsche-12"> <span id="mw-reference-text-cite_note-gotzsche-12" class="mw-reference-text"><cite id="CITEREFGøtzsche2013" class="citation book cs1">Gøtzsche, Peter (2013). <i>Deadly medicines and organised crime<span>&nbsp;</span>: how big pharma has corrupted healthcare</i>. London [u.a.]: Radcliffe Publ. p.<span>&nbsp;</span>185. ISBN<span>&nbsp;</span><bdi>9781846198847</bdi>.</cite></span></li><li id="cite_note-NYTapprove-13"> <span id="mw-reference-text-cite_note-NYTapprove-13" class="mw-reference-text"><cite id="CITEREFLeary1997" class="citation news cs1">Leary, Warren (31 January 1997). <a href="javascript:if(confirm('https://www.nytimes.com/1997/01/31/us/new-class-of-diabetes-drug-is-approved.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1997/01/31/us/new-class-of-diabetes-drug-is-approved.html'" tppabs="https://www.nytimes.com/1997/01/31/us/new-class-of-diabetes-drug-is-approved.html" class="external text external">"New Class of Diabetes Drug Is Approved"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 December</span> 2012</span>.</cite></span></li><li id="cite_note-ICIS-14"> <span id="mw-reference-text-cite_note-ICIS-14" class="mw-reference-text"><cite id="CITEREFSinclair1997" class="citation news cs1">Sinclair, Neil (31 July 1997). <a href="javascript:if(confirm('http://www.icis.com/Articles/1997/07/31/34199/glaxo-wellcome-gets-approval-for-romozin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.icis.com/Articles/1997/07/31/34199/glaxo-wellcome-gets-approval-for-romozin.html'" tppabs="http://www.icis.com/Articles/1997/07/31/34199/glaxo-wellcome-gets-approval-for-romozin.html" class="external text external">"Glaxo Wellcome gets approval for Romozin"</a>. <i>ICIS News</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 December</span> 2012</span>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020720a_s001_thru_s007.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020720a_s001_thru_s007.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020720a_s001_thru_s007.pdf" class="external text external">"www.accessdata.fda.gov"</a> <span class="cs1-format">(PDF)</span>.</cite></span></li><li id="cite_note-BBC-16"> <span id="mw-reference-text-cite_note-BBC-16" class="mw-reference-text"><cite id="CITEREFBritish_Broadcasting_Corporation1997" class="citation news cs1">British Broadcasting Corporation (1 December 1997). <a href="javascript:if(confirm('http://news.bbc.co.uk/2/hi/uk_news/36090.stm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://news.bbc.co.uk/2/hi/uk_news/36090.stm'" tppabs="http://news.bbc.co.uk/2/hi/uk_news/36090.stm" class="external text external">"Diabetes drug withdrawn from sale"</a>. <i>BBC</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 December</span> 2012</span>.</cite></span></li><li id="cite_note-Fisher-17"> <span id="mw-reference-text-cite_note-Fisher-17" class="mw-reference-text"><cite id="CITEREFFisher1998" class="citation news cs1">Fisher, Lawrence (17 January 1998). <a href="javascript:if(confirm('https://www.nytimes.com/1998/01/17/business/drug-makers-threshold-new-therapy-with-dose-biotechnology-big-change-ahead.html?pagewanted=all&src=pm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1998/01/17/business/drug-makers-threshold-new-therapy-with-dose-biotechnology-big-change-ahead.html?pagewanted=all&src=pm'" tppabs="https://www.nytimes.com/1998/01/17/business/drug-makers-threshold-new-therapy-with-dose-biotechnology-big-change-ahead.html?pagewanted=all&src=pm" class="external text external">"Drug Makers at Threshold of a New Therapy; With a Dose of Biotechnology, Big Change Is Ahead in the Treatment of Diabetes"</a>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 December</span> 2012</span>.</cite></span></li><li id="cite_note-NIH-18"> <span id="mw-reference-text-cite_note-NIH-18" class="mw-reference-text"><cite id="CITEREFDiabetes_Prevention_Research_Group1999" class="citation journal cs1">Diabetes Prevention Research Group (April 1999). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351026'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351026" class="external text external">"Design and methods for a clinical trial in the prevention of type 2 diabetes"</a>. <i>Diabetes Care</i>. <b>22</b> (4): 623–634. doi:<a href="javascript:if(confirm('https://doi.org/10.2337%2Fdiacare.22.4.623  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2337%2Fdiacare.22.4.623'" tppabs="https://doi.org/10.2337%2Fdiacare.22.4.623" class="external text external">10.2337/diacare.22.4.623</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351026'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351026" class="external text external">1351026</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10189543  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10189543'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10189543" class="external text external">10189543</a>.</cite></span></li><li id="cite_note-NEJM-19"> <span id="mw-reference-text-cite_note-NEJM-19" class="mw-reference-text"><cite id="CITEREFDiabetes_Prevention_Program_Research_Group2002" class="citation journal cs1">Diabetes Prevention Program Research Group (7 February 2002). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1370926  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1370926'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1370926" class="external text external">"Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin"</a>. <i>The New England Journal of Medicine</i>. <b>346</b> (6): 393–403. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa012512  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa012512'" tppabs="https://doi.org/10.1056%2FNEJMoa012512" class="external text external">10.1056/NEJMoa012512</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1370926  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1370926'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1370926" class="external text external">1370926</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11832527  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11832527'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11832527" class="external text external">11832527</a>.</cite></span></li><li id="cite_note-Gale-20"> <span id="mw-reference-text-cite_note-Gale-20" class="mw-reference-text"><cite id="CITEREFGale2006" class="citation journal cs1">Gale, Edwin (January 2006). <a href="javascript:if(confirm('https://doi.org/10.1007/s00125-005-0074-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007/s00125-005-0074-6'" tppabs="https://doi.org/10.1007/s00125-005-0074-6" class="external text external">"Troglitazone: the lesson that nobody learned?"</a>. <i>Diabetologia</i>. <b>49</b> (1): 1–6. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00125-005-0074-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00125-005-0074-6'" tppabs="https://doi.org/10.1007%2Fs00125-005-0074-6" class="external text external">10.1007/s00125-005-0074-6</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16362281  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16362281'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16362281" class="external text external">16362281</a>.</cite></span></li><li id="cite_note-LATimes2-21"> <span id="mw-reference-text-cite_note-LATimes2-21" class="mw-reference-text"><cite class="citation news cs1">Willman, David (16 August 2000). <a href="javascript:if(confirm('http://www.pulitzer.org/archives/6486  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pulitzer.org/archives/6486'" tppabs="http://www.pulitzer.org/archives/6486" class="external text external">"FDA's Approval and Delay in Withdrawing Rezulin Probed"</a>. <i>The Los Angeles Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 December</span> 2012</span>.</cite></span></li><li id="cite_note-LATimes3-22"> <span id="mw-reference-text-cite_note-LATimes3-22" class="mw-reference-text"><cite class="citation news cs1">Willman, David (10 March 2000). <a href="javascript:if(confirm('http://www.pulitzer.org/archives/6483  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pulitzer.org/archives/6483'" tppabs="http://www.pulitzer.org/archives/6483" class="external text external">"Fears Grow Over Delay in Removing Rezulin"</a>. <i>The Los Angeles Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 December</span> 2012</span>.</cite></span></li><li id="cite_note-FDAalert-23"> <span id="mw-reference-text-cite_note-FDAalert-23" class="mw-reference-text"><cite id="CITEREFU.S._Food_and_Drug_Administration" class="citation web cs1">U.S. Food and Drug Administration. <a href="javascript:if(confirm('https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm173081.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm173081.htm'" tppabs="https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm173081.htm" class="external text external">"2000 Safety Alerts for Human Medical Products"</a>. U.S. Food and Drug Administration<span class="reference-accessdate">. Retrieved <span class="nowrap">12 December</span> 2012</span>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite class="citation news cs1">Willman, David (March 17, 2000). <a href="javascript:if(confirm('http://articles.latimes.com/2000/mar/17/news/mn-9908  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://articles.latimes.com/2000/mar/17/news/mn-9908'" tppabs="http://articles.latimes.com/2000/mar/17/news/mn-9908" class="external text external">"Physician Who Opposes Rezulin Is Threatened by FDA With Dismissal"</a>. <i>Los Angeles Times</i>.</cite></span></li><li id="cite_note-Pfizer-25"> <span id="mw-reference-text-cite_note-Pfizer-25" class="mw-reference-text"><cite id="CITEREFPfizer" class="citation web cs1">Pfizer. <a href="javascript:if(confirm('http://people.stern.nyu.edu/jbilders/Pdf/pfizer2001ar.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://people.stern.nyu.edu/jbilders/Pdf/pfizer2001ar.pdf'" tppabs="http://people.stern.nyu.edu/jbilders/Pdf/pfizer2001ar.pdf" class="external text external">"Pfizer Annual Report 2001"</a> <span class="cs1-format">(PDF)</span>. Pfizer<span class="reference-accessdate">. Retrieved <span class="nowrap">12 December</span> 2012</span>.</cite></span></li><li id="cite_note-:0-26"> <span id="mw-reference-text-cite_note-:0-26" class="mw-reference-text"><cite id="CITEREFKassahunPearsonTangMcIntosh2001" class="citation journal cs1">Kassahun, Kelem; Pearson, Paul G.; Tang, Wei; McIntosh, Ian; Leung, Kwan; Elmore, Charles; Dean, Dennis; Wang, Regina; Doss, George (2001-01-01). "Studies on the Metabolism of Troglitazone to Reactive Intermediates in Vitro and in Vivo. Evidence for Novel Biotransformation Pathways Involving Quinone Methide Formation and Thiazolidinedione Ring Scission†". <i>Chemical Research in Toxicology</i>. <b>14</b> (1): 62–70. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Ftx000180q  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Ftx000180q'" tppabs="https://doi.org/10.1021%2Ftx000180q" class="external text external">10.1021/tx000180q</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0893-228X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0893-228X'" tppabs="https://www.worldcat.org/issn/0893-228X" class="external text external">0893-228X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11170509  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11170509'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11170509" class="external text external">11170509</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFFunkPonelleScheuermannPantze2001" class="citation journal cs1">Funk, Christoph; Ponelle, Christiane; Scheuermann, Gerd; Pantze, Michael (2001-03-01). "Cholestatic Potential of Troglitazone as a Possible Factor Contributing to Troglitazone-Induced Hepatotoxicity: In Vivo and in Vitro Interaction at the Canalicular Bile Salt Export Pump (Bsep) in the Rat". <i>Molecular Pharmacology</i>. <b>59</b> (3): 627–635. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fmol.59.3.627  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fmol.59.3.627'" tppabs="https://doi.org/10.1124%2Fmol.59.3.627" class="external text external">10.1124/mol.59.3.627</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1521-0111  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1521-0111'" tppabs="https://www.worldcat.org/issn/1521-0111" class="external text external">1521-0111</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11179459  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11179459'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11179459" class="external text external">11179459</a>.</cite></span></li><li id="cite_note-:1-28"> <span id="mw-reference-text-cite_note-:1-28" class="mw-reference-text"><cite id="CITEREFDixitBharatam2011" class="citation journal cs1">Dixit, Vaibhav A.; Bharatam, Prasad V. (2011-07-18). "Toxic Metabolite Formation from Troglitazone (TGZ): New Insights from a DFT Study". <i>Chemical Research in Toxicology</i>. <b>24</b> (7): 1113–1122. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Ftx200110h  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Ftx200110h'" tppabs="https://doi.org/10.1021%2Ftx200110h" class="external text external">10.1021/tx200110h</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0893-228X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0893-228X'" tppabs="https://www.worldcat.org/issn/0893-228X" class="external text external">0893-228X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21657230  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21657230'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21657230" class="external text external">21657230</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFMasubuchi2006" class="citation journal cs1">Masubuchi, Yasuhiro (2006-10-01). "Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review". <i>Drug Metabolism and Pharmacokinetics</i>. <b>21</b> (5): 347–356. doi:<a href="javascript:if(confirm('https://doi.org/10.2133%2Fdmpk.21.347  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2133%2Fdmpk.21.347'" tppabs="https://doi.org/10.2133%2Fdmpk.21.347" class="external text external">10.2133/dmpk.21.347</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1347-4367  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1347-4367'" tppabs="https://www.worldcat.org/issn/1347-4367" class="external text external">1347-4367</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17072088  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17072088'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17072088" class="external text external">17072088</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFSalamoneColinGrillier-VuissozKuntz2012" class="citation journal cs1">Salamone, Stéphane; Colin, Christelle; Grillier-Vuissoz, Isabelle; Kuntz, Sandra; Mazerbourg, Sabine; Flament, Stéphane; Martin, Hélène; Richert, Lysiane; Chapleur, Yves (2012-05-01). "Synthesis of new troglitazone derivatives: Anti-proliferative activity in breast cancer cell lines and preliminary toxicological study". <i>European Journal of Medicinal Chemistry</i>. <b>51</b>: 206–215. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ejmech.2012.02.044  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ejmech.2012.02.044'" tppabs="https://doi.org/10.1016%2Fj.ejmech.2012.02.044" class="external text external">10.1016/j.ejmech.2012.02.044</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22409968  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22409968'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22409968" class="external text external">22409968</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFFeeley2009" class="citation news cs1">Feeley, Jef (March 31, 2009). <a href="javascript:if(confirm('https://www.bloomberg.com/apps/news?pid=newsarchive&sid=act0akCefQwo  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bloomberg.com/apps/news?pid=newsarchive&sid=act0akCefQwo'" tppabs="https://www.bloomberg.com/apps/news?pid=newsarchive&sid=act0akCefQwo" class="external text external">"Pfizer Ends Rezulin Cases With $205 Million to Spare"</a>. <i>Bloomberg</i><span class="reference-accessdate">. Retrieved <span class="nowrap">6 April</span> 2014</span>.</cite></span></li></ol></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('http://www.diabetesmonitor.com/rezulin.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.diabetesmonitor.com/rezulin.htm'" tppabs="http://www.diabetesmonitor.com/rezulin.htm" class="external text external">Diabetes Monitor</a> article on troglitazone</li>
<li><a href="javascript:if(confirm('https://web.archive.org/web/20040405083219/http://www.rxlist.com/cgi/generic/troglitazone.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20040405083219/http://www.rxlist.com/cgi/generic/troglitazone.htm'" tppabs="https://web.archive.org/web/20040405083219/http://www.rxlist.com/cgi/generic/troglitazone.htm" class="external text external">RxList</a> article on troglitazone</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Oral_anti-diabetic_drugs,_insulins_and_insulin_analogs,_and_other_drugs_used_in_diabetes_(A10)" style="padding:3px"><table class="nowraplinks mw-collapsible expanded navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Oral_anti-diabetic_drugs,_insulins_and_insulin_analogs,_and_other_drugs_used_in_diabetes_(A10)" style="font-size:114%;margin:0 4em">Oral anti-diabetic drugs, <a href="Insulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Insulin" title="Insulin">insulins</a> and insulin analogs, and other drugs used in diabetes (A10)</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible mw-collapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Insulins/insulin_analogs" style="font-size:114%;margin:0 4em"><a href="Insulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Insulin" title="Insulin">Insulins</a>/insulin analogs</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><i>fast-acting</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Insulin aspart</li>
<li>Insulin glulisine</li>
<li>Insulin lispro</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>short-acting</i></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Regular insulin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>long-acting</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Insulin detemir</li>
<li>Insulin glargine (+lixisenatide)</li>
<li>NPH insulin</li>
<li>Lente insulin<sup>‡</sup></li>
<li>Ultralente insulin<sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>ultra-long-acting</i></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Insulin degludec (+insulin aspart, +liraglutide)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><i>inhalable</i></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Exubera<sup>‡</sup></li>
<li>Afreeza</li></ul>
</div></td></tr></tbody></table><div>
<div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks mw-collapsible mw-collapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Non-insulins" style="font-size:114%;margin:0 4em">Non-insulins</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Insulin sensitizers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Biguanides</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Buformin.htm" tppabs="https://ptable.com/wiki/compounds/A/Buformin" title="Buformin">Buformin</a><sup>‡</sup></li>
<li><a href="Metformin.htm" tppabs="https://ptable.com/wiki/compounds/A/Metformin" title="Metformin">Metformin</a><sup>#</sup></li>
<li><a href="Phenformin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenformin" title="Phenformin">Phenformin</a><sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Thiazolidinedione.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiazolidinedione" title="Thiazolidinedione">TZDs</a>/"glitazones" (PPAR)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Ciglitazone<sup>§</sup></li>
<li>Darglitazone<sup>§</sup></li>
<li>Englitazone<sup>§</sup></li>
<li>Lobeglitazone</li>
<li>Netoglitazone<sup>§</sup></li>
<li><a href="Pioglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pioglitazone" title="Pioglitazone">Pioglitazone</a></li>
<li>Rivoglitazone<sup>†</sup></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Rosiglitazone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Rosiglitazone'" tppabs="https://ptable.com/wiki/compounds/A/Rosiglitazone" title="Rosiglitazone">Rosiglitazone</a></li>
<li><a href="Troglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Troglitazone" title="Troglitazone">Troglitazone</a><sup>‡</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Dual PPAR agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aleglitazar<sup>†</sup></li>
<li>Muraglitazar<sup>§</sup></li>
<li>Saroglitazar</li>
<li>Tesaglitazar<sup>§</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Secretagogues</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">K<sup>+</sup><sub>ATP</sub></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Sulfonylureas</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>1st generation</i>: <a href="Acetohexamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetohexamide" title="Acetohexamide">Acetohexamide</a></li>
<li><a href="Carbutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbutamide" title="Carbutamide">Carbutamide</a></li>
<li><a href="Chlorpropamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpropamide" title="Chlorpropamide">Chlorpropamide</a></li>
<li><span class="new">Glycyclamide</span></li>
<li>Metahexamide</li>
<li><a href="Tolazamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolazamide" title="Tolazamide">Tolazamide</a></li>
<li><a href="Tolbutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolbutamide" title="Tolbutamide">Tolbutamide</a></li></ul>

<ul><li><i>2nd generation</i>: <a href="Glibenclamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glibenclamide" title="Glibenclamide">Glibenclamide (glyburide)</a></li>
<li>Glibornuride</li>
<li>Glicaramide</li>
<li><a href="Gliclazide.htm" tppabs="https://ptable.com/wiki/compounds/A/Gliclazide" title="Gliclazide">Gliclazide</a><sup>#</sup></li>
<li><a href="Glimepiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Glimepiride" title="Glimepiride">Glimepiride</a></li>
<li><a href="Glipizide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glipizide" title="Glipizide">Glipizide</a></li>
<li><a href="Gliquidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gliquidone" title="Gliquidone">Gliquidone</a></li>
<li><a href="Glisoxepide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glisoxepide" title="Glisoxepide">Glisoxepide</a></li>
<li>Glyclopyramide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Meglitinides/"glinides"</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Mitiglinide.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitiglinide" title="Mitiglinide">Mitiglinide</a></li>
<li><a href="Nateglinide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nateglinide" title="Nateglinide">Nateglinide</a></li>
<li><a href="Repaglinide.htm" tppabs="https://ptable.com/wiki/compounds/A/Repaglinide" title="Repaglinide">Repaglinide</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">GLP-1 receptor agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Albiglutide<sup>‡</sup></li>
<li>Dulaglutide</li>
<li><a href="Exenatide.htm" tppabs="https://ptable.com/wiki/compounds/A/Exenatide" title="Exenatide">Exenatide</a></li>
<li>Liraglutide</li>
<li>Lixisenatide</li>
<li>Semaglutide</li>
<li>Taspoglutide<sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">DPP-4 inhibitors/"gliptins"</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alogliptin</li>
<li>Anagliptin</li>
<li>Evogliptin</li>
<li><span class="new">Garvagliptin</span></li>
<li>Gemigliptin</li>
<li>Gosogliptin</li>
<li>Linagliptin</li>
<li><span class="new">Melogliptin</span></li>
<li>Omarigliptin</li>
<li>Saxagliptin</li>
<li><a href="Sitagliptin.htm" tppabs="https://ptable.com/wiki/compounds/A/Sitagliptin" title="Sitagliptin">Sitagliptin</a></li>
<li>Teneligliptin</li>
<li>Trelagliptin</li>
<li>Vildagliptin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"> FFAR1 agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">Fasiglifam</span><sup>†</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Aldose reductase inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Epalrestat.htm" tppabs="https://ptable.com/wiki/compounds/A/Epalrestat" title="Epalrestat">Epalrestat</a></li>
<li>Fidarestat<sup>§</sup></li>
<li>Ranirestat<sup>†</sup></li>
<li><a href="Tolrestat.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolrestat" title="Tolrestat">Tolrestat</a><sup>‡</sup></li>
<li>Zenarestat<sup>§</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Alpha-glucosidase inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Acarbose.htm" tppabs="https://ptable.com/wiki/compounds/A/Acarbose" title="Acarbose">Acarbose</a></li>
<li><a href="Miglitol.htm" tppabs="https://ptable.com/wiki/compounds/A/Miglitol" title="Miglitol">Miglitol</a></li>
<li><a href="Voglibose.htm" tppabs="https://ptable.com/wiki/compounds/A/Voglibose" title="Voglibose">Voglibose</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Amylin analog</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Pramlintide.htm" tppabs="https://ptable.com/wiki/compounds/A/Pramlintide" title="Pramlintide">Pramlintide</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">SGLT2 inhibitors/"gliflozins"</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Canagliflozin</li>
<li>Dapagliflozin</li>
<li>Empagliflozin</li>
<li>Ertugliflozin</li>
<li>Ipragliflozin</li>
<li>Remogliflozin<sup>§</sup></li>
<li>Sergliflozin<sup>§</sup></li>
<li>Tofogliflozin<sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Benfluorex<sup>‡</sup></li>
<li><a href="Bromocriptine.htm" tppabs="https://ptable.com/wiki/compounds/A/Bromocriptine" title="Bromocriptine">Bromocriptine</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combinations</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><td colspan="2" class="navbox-list navbox-even" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alogliptin/metformin</li>
<li>Canagliflozin/metformin</li>
<li>Dapagliflozin/metformin</li>
<li>Dapagliflozin/saxagliptin</li>
<li>Dapagliflozin/saxagliptin/metformin</li>
<li>Empagliflozin/metformin</li>
<li><span class="new">Gemigliptin/rosuvastatin</span></li>
<li>Glibenclamide (glyburide)/metformin</li>
<li><span class="new">Glimepiride/rosiglitazone</span></li>
<li><span class="new">Linagliptin/empagliflozin</span></li>
<li><a href="Metformin.htm" tppabs="https://ptable.com/wiki/compounds/A/Linagliptin/metformin" title="Linagliptin/metformin" class="mw-redirect">Linagliptin/metformin</a></li>
<li><span class="new">Metformin/acarbose</span></li>
<li>Metformin/ertugliflozin</li>
<li><span class="new">Metformin/evogliptin</span></li>
<li><span class="new">Metformin/gemigliptin</span></li>
<li><span class="new">Metformin/repaglinide</span></li>
<li><span class="new">Metformin/sulfonylureas</span></li>
<li><span class="new">Phenformin/sulfonylureas</span></li>
<li>Pioglitazone/alogliptin</li>
<li>Pioglitazone/glimepiride</li>
<li>Pioglitazone/metformin</li>
<li><span class="new">Pioglitazone/sitagliptin</span></li>
<li><a href="Metformin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rosiglitazone/metformin" title="Rosiglitazone/metformin" class="mw-redirect">Rosiglitazone/metformin</a></li>
<li><a href="Metformin.htm" tppabs="https://ptable.com/wiki/compounds/A/Saxagliptin/metformin" title="Saxagliptin/metformin" class="mw-redirect">Saxagliptin/metformin</a></li>
<li><span class="new">Sitagliptin/ertugliflozin</span></li>
<li>Sitagliptin/metformin</li>
<li>Sitagliptin/simvastatin</li>
<li>Vildagliptin/metformin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div>
<div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table><div></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="PPAR_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="PPAR_modulators" style="font-size:114%;margin:0 4em"><abbr>PPAR</abbr> modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>PPARα</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> 15-HETE</li>
<li><span class="new">15-HpETE</span></li>
<li>Aleglitazar</li>
<li>Aluminium clofibrate</li>
<li><a href="Arachidonic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Arachidonic_acid" title="Arachidonic acid">Arachidonic acid</a></li>
<li><a href="Bezafibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Bezafibrate" title="Bezafibrate">Bezafibrate</a></li>
<li><a href="Clofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Clofibrate" title="Clofibrate">Clofibrate</a></li>
<li><span class="new">CP-775146</span></li>
<li><a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">Daidzein</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (prasterone) (in rodents)</li>
<li>Elafibranor</li>
<li>Etomoxir</li>
<li><a href="Fenofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenofibrate" title="Fenofibrate">Fenofibrate</a></li>
<li><a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">Genistein</a></li>
<li><a href="Gemfibrozil.htm" tppabs="https://ptable.com/wiki/compounds/A/Gemfibrozil" title="Gemfibrozil">Gemfibrozil</a></li>
<li><span class="new">GW-7647</span></li>
<li><span class="new">Lanifibranor</span></li>
<li>Leukotriene B<sub>4</sub></li>
<li><span class="new">LG-101506</span></li>
<li><span class="new">LG-100754</span></li>
<li>Lobeglitazone</li>
<li>Muraglitazar</li>
<li>Oleylethanolamide</li>
<li>Palmitoylethanolamide</li>
<li>Pemafibrate</li>
<li><a href="Perfluorononanoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Perfluorononanoic_acid" title="Perfluorononanoic acid">Perfluorononanoic acid</a></li>
<li><a href="Perfluorooctanoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Perfluorooctanoic_acid" title="Perfluorooctanoic acid">Perfluorooctanoic acid</a></li>
<li><a href="Pioglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pioglitazone" title="Pioglitazone">Pioglitazone</a></li>
<li>Saroglitazar</li>
<li>Sodelglitazar</li>
<li>Tesaglitazar</li>
<li>Tetradecylthioacetic acid</li>
<li><a href="Troglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Troglitazone" title="Troglitazone">Troglitazone</a></li>
<li><span class="new">WY-14643</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">GW-6471</span></li>
<li>MK-886</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>PPARδ</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> 15-HETE</li>
<li><span class="new">15-HpETE</span></li>
<li><a href="Arachidonic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Arachidonic_acid" title="Arachidonic acid">Arachidonic acid</a></li>
<li><a href="Bezafibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Bezafibrate" title="Bezafibrate">Bezafibrate</a></li>
<li><a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">Daidzein</a></li>
<li>Elafibranor</li>
<li><span class="new">Fonadelpar</span></li>
<li><a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">Genistein</a></li>
<li>GW-0742</li>
<li>GW-501516</li>
<li><span class="new">L-165,041</span></li>
<li><span class="new">Lanifibranor</span></li>
<li><span class="new">LG-101506</span></li>
<li>Seladelpar</li>
<li>Sodelglitazar</li>
<li>Tetradecylthioacetic acid</li></ul>

<ul><li><i>Antagonists:</i> <span class="new">FH-535</span></li>
<li><span class="new">GSK-0660</span></li>
<li><span class="new">GSK-3787</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>PPARγ</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">5-Oxo-ETE</span></li>
<li><span class="new">5-Oxo-15-hydroxy-ETE</span></li>
<li>15-Deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub></li>
<li>15-HETE</li>
<li><span class="new">15-HpETE</span></li>
<li>Aleglitazar</li>
<li><a href="Arachidonic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Arachidonic_acid" title="Arachidonic acid">Arachidonic acid</a></li>
<li><span class="new">Balaglitazone</span></li>
<li><a href="Berberine.htm" tppabs="https://ptable.com/wiki/compounds/A/Berberine" title="Berberine">Berberine</a></li>
<li><a href="Bezafibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Bezafibrate" title="Bezafibrate">Bezafibrate</a></li>
<li><a href="Cannabidiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Cannabidiol" title="Cannabidiol">Cannabidiol</a></li>
<li><span class="new">Cevoglitazar</span></li>
<li>Ciglitazone</li>
<li><a href="Daidzein.htm" tppabs="https://ptable.com/wiki/compounds/A/Daidzein" title="Daidzein">Daidzein</a></li>
<li>Darglitazone</li>
<li><span class="new">Edaglitazone</span></li>
<li><span class="new">Efatutazone</span></li>
<li>Englitazone</li>
<li>Etalocib</li>
<li>Farglitazar</li>
<li><a href="Genistein.htm" tppabs="https://ptable.com/wiki/compounds/A/Genistein" title="Genistein">Genistein</a></li>
<li><span class="new">GW-1929</span></li>
<li><a href="Ibuprofen.htm" tppabs="https://ptable.com/wiki/compounds/A/Ibuprofen" title="Ibuprofen">Ibuprofen</a></li>
<li><span class="new">Imiglitazar</span></li>
<li>Indeglitazar</li>
<li><span class="new">Lanifibranor</span></li>
<li><span class="new">LG-100268</span></li>
<li><span class="new">LG-100754</span></li>
<li><span class="new">LG-101506</span></li>
<li>Lobeglitazone</li>
<li>Muraglitazar (muroglitazar)</li>
<li><span class="new">nTZDpa</span></li>
<li><span class="new">Naveglitazar</span></li>
<li>Netoglitazone</li>
<li><span class="new">Oxeglitazar</span></li>
<li><span class="new">Peliglitazar</span></li>
<li><span class="new">Pemaglitazar</span></li>
<li><a href="Perfluorononanoic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Perfluorononanoic_acid" title="Perfluorononanoic acid">Perfluorononanoic acid</a></li>
<li><a href="Pioglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pioglitazone" title="Pioglitazone">Pioglitazone</a></li>
<li><span class="new">Prostaglandin J<sub>2</sub></span></li>
<li><span class="new">Ragaglitazar</span></li>
<li><span class="new">Reglitazar</span></li>
<li>Rivoglitazone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Rosiglitazone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Rosiglitazone'" tppabs="https://ptable.com/wiki/compounds/A/Rosiglitazone" title="Rosiglitazone">Rosiglitazone</a></li>
<li><span class="new">RS5444</span></li>
<li>Saroglitazar</li>
<li><span class="new">Sipoglitazar</span></li>
<li>Sodelglitazar</li>
<li><a href="Telmisartan.htm" tppabs="https://ptable.com/wiki/compounds/A/Telmisartan" title="Telmisartan">Telmisartan</a></li>
<li>Tesaglitazar</li>
<li><a href="Troglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Troglitazone" title="Troglitazone">Troglitazone</a></li></ul>

<ul><li><i><abbr>SPPARMs</abbr>:</i> <a href="Bisphenol_A_diglycidyl_ether.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A_diglycidyl_ether" title="Bisphenol A diglycidyl ether">BADGE</a></li>
<li>EPI-001</li>
<li><span class="new">INT-131</span></li>
<li><span class="new">MK-0533</span></li>
<li><span class="new">S26948</span></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">FH-535</span></li>
<li><span class="new">GW-9662</span></li>
<li><span class="new">SR-202</span></li>
<li><span class="new">T-0070907</span></li></ul>

<ul><li><i>Unknown:</i> <span class="new">SR-1664</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Non-selective</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <a href="Ciprofibrate.htm" tppabs="https://ptable.com/wiki/compounds/A/Ciprofibrate" title="Ciprofibrate">Ciprofibrate</a></li>
<li>Clinofibrate</li>
<li>Clofibride</li>
<li>Englitazone</li>
<li>Etofibrate</li>
<li>Farglitazar</li>
<li>Netoglitazone</li>
<li>Ronifibrate</li>
<li>Rivoglitazone</li>
<li>Simfibrate</li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i>Receptor/signaling modulators</i></dd></dl>
</div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Xenobiotic-sensing_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Xenobiotic-sensing_receptor_modulators" style="font-size:114%;margin:0 4em">Xenobiotic-sensing receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>CAR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">6,7-Dimethylesculetin</span></li>
<li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li><a href="Artemisinin.htm" tppabs="https://ptable.com/wiki/compounds/A/Artemisinin" title="Artemisinin">Artemisinin</a></li>
<li><span class="new">Benfuracarb</span></li>
<li><a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">Carbamazepine</a></li>
<li><a href="Carvedilol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carvedilol" title="Carvedilol">Carvedilol</a></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Chrysin.htm" tppabs="https://ptable.com/wiki/compounds/A/Chrysin" title="Chrysin">Chrysin</a></li>
<li><span class="new">CITCO</span></li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a></li>
<li><a href="Cypermethrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cypermethrin" title="Cypermethrin">Cypermethrin</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (prasterone)</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li><a href="Ellagic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ellagic_acid" title="Ellagic acid">Ellagic acid</a></li>
<li><a href="Griseofulvin.htm" tppabs="https://ptable.com/wiki/compounds/A/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li>
<li><a href="Methoxychlor.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxychlor" title="Methoxychlor">Methoxychlor</a></li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li><a href="Nevirapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nevirapine" title="Nevirapine">Nevirapine</a></li>
<li><a href="Nicardipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><span class="new">Octicizer</span></li>
<li><a href="Permethrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Permethrin" title="Permethrin">Permethrin</a></li>
<li><a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li>Pregnanedione (5β-dihydroprogesterone)</li>
<li><a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">Reserpine</a></li>
<li><span class="new">TCPOBOP</span></li>
<li><a href="Telmisartan.htm" tppabs="https://ptable.com/wiki/compounds/A/Telmisartan" title="Telmisartan">Telmisartan</a></li>
<li><a href="Tolnaftate.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolnaftate" title="Tolnaftate">Tolnaftate</a></li>
<li><a href="Troglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Troglitazone" title="Troglitazone">Troglitazone</a></li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">3,17β-Estradiol</span></li>
<li><span class="new">3α-Androstanol</span></li>
<li>3α-Androstenol</li>
<li><span class="new">3β-Androstanol</span></li>
<li><span class="new">17-Androstanol</span></li>
<li><a href="Allyl_isothiocyanate.htm" tppabs="https://ptable.com/wiki/compounds/A/Allyl_isothiocyanate" title="Allyl isothiocyanate">AITC</a></li>
<li>Ethinylestradiol</li>
<li>Meclizine</li>
<li><span class="new">Nigramide J</span></li>
<li><a href="Okadaic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Okadaic_acid" title="Okadaic acid">Okadaic acid</a></li>
<li>PK-11195</li>
<li><span class="new">S-07662</span></li>
<li><span class="new">T-0901317</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>PXR</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> 17α-Hydroxypregnenolone</li>
<li>17α-Hydroxyprogesterone</li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%944-Androstenedione" title="Δ4-Androstenedione" class="mw-redirect">Δ<sup>4</sup>-Androstenedione</a></li>
<li><a href="Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%945-Androstenediol" title="Δ5-Androstenediol" class="mw-redirect">Δ<sup>5</sup>-Androstenediol</a></li>
<li>Δ<sup>5</sup>-Androstenedione</li>
<li><span class="new">AA-861</span></li>
<li>Allopregnanediol</li>
<li><a href="5α-Dihydroprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">Allopregnanedione (5α-dihydroprogesterone)</a></li>
<li><a href="Allopregnanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopregnanolone" title="Allopregnanolone">Allopregnanolone (brexanolone)</a></li>
<li>Alpha-Lipoic acid</li>
<li>Ambrisentan</li>
<li>AMI-193</li>
<li>Amlodipine besylate</li>
<li>Antimycotics</li>
<li><a href="Artemisinin.htm" tppabs="https://ptable.com/wiki/compounds/A/Artemisinin" title="Artemisinin">Artemisinin</a></li>
<li><a href="Aurothioglucose.htm" tppabs="https://ptable.com/wiki/compounds/A/Aurothioglucose" title="Aurothioglucose">Aurothioglucose</a></li>
<li>Bile acids</li>
<li><a href="Bithionol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bithionol" title="Bithionol">Bithionol</a></li>
<li><a href="Bosentan.htm" tppabs="https://ptable.com/wiki/compounds/A/Bosentan" title="Bosentan">Bosentan</a></li>
<li><span class="new">Bumecaine</span></li>
<li>Cafestol</li>
<li><a href="Cephaloridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cephaloridine" title="Cephaloridine">Cephaloridine</a></li>
<li><a href="Cefradine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cephradine" title="Cephradine" class="mw-redirect">Cephradine</a></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li>Ciglitazone</li>
<li><a href="Clindamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clindamycin" title="Clindamycin">Clindamycin</a></li>
<li>Clofenvinfos</li>
<li><a href="Chloroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloroxine" title="Chloroxine">Chloroxine</a></li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="Colforsin.htm" tppabs="https://ptable.com/wiki/compounds/A/Colforsin" title="Colforsin">Colforsin</a></li>
<li><a href="Corticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Corticosterone" title="Corticosterone">Corticosterone</a></li>
<li><a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Demecolcine.htm" tppabs="https://ptable.com/wiki/compounds/A/Demecolcine" title="Demecolcine">Demecolcine</a></li>
<li><a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">Dexamethasone</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (prasterone)</li>
<li><a href="Dehydroepiandrosterone_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">DHEA-S</a> (prasterone sulfate)</li>
<li>Dibunate sodium</li>
<li>Diclazuril</li>
<li><a href="Dicloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicloxacillin" title="Dicloxacillin">Dicloxacillin</a></li>
<li><a href="Dimercaprol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimercaprol" title="Dimercaprol">Dimercaprol</a></li>
<li><span class="new">Dinaline</span></li>
<li><a href="Docetaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Docetaxel" title="Docetaxel">Docetaxel</a></li>
<li>Docusate calcium</li>
<li>Dodecylbenzenesulfonic acid</li>
<li>Dronabinol</li>
<li>Droxidopa</li>
<li><a href="Vinburnine.htm" tppabs="https://ptable.com/wiki/compounds/A/Eburnamonine" title="Eburnamonine" class="mw-redirect">Eburnamonine</a></li>
<li>Ecopipam</li>
<li>Enzacamene</li>
<li>Epothilone B</li>
<li><a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">Erythromycin</a></li>
<li>Famprofazone</li>
<li><span class="new">Febantel</span></li>
<li><a href="Felodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Felodipine" title="Felodipine">Felodipine</a></li>
<li><a href="Fenbendazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenbendazole" title="Fenbendazole">Fenbendazole</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><a href="Flucloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Flucloxacillin" title="Flucloxacillin">Flucloxacillin</a></li>
<li><a href="Fluorometholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorometholone" title="Fluorometholone">Fluorometholone</a></li>
<li><a href="Griseofulvin.htm" tppabs="https://ptable.com/wiki/compounds/A/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li>
<li>Guggulsterone</li>
<li><a href="Haloprogin.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloprogin" title="Haloprogin">Haloprogin</a></li>
<li>Hetacillin potassium</li>
<li><a href="Hyperforin.htm" tppabs="https://ptable.com/wiki/compounds/A/Hyperforin" title="Hyperforin">Hyperforin</a></li>
<li><i>Hypericum perforatum</i> (St John's wort)</li>
<li>Indinavir sulfate</li>
<li>Lasalocid sodium</li>
<li><a href="Levothyroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levothyroxine" title="Levothyroxine">Levothyroxine</a></li>
<li><a href="Linolenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linolenic_acid" title="Linolenic acid">Linolenic acid</a></li>
<li><span class="new">LOE-908</span></li>
<li><a href="Loratadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loratadine" title="Loratadine">Loratadine</a></li>
<li><a href="Lovastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lovastatin" title="Lovastatin">Lovastatin</a></li>
<li>Meclizine</li>
<li><a href="Metacycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metacycline" title="Metacycline">Metacycline</a></li>
<li><a href="Methylprednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylprednisolone" title="Methylprednisolone">Methylprednisolone</a></li>
<li><a href="Metyrapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Metyrapone" title="Metyrapone">Metyrapone</a></li>
<li><a href="Mevastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mevastatin" title="Mevastatin">Mevastatin</a></li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="Nafcillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Nafcillin" title="Nafcillin">Nafcillin</a></li>
<li><a href="Nicardipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li><a href="Nifedipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nifedipine" title="Nifedipine">Nifedipine</a></li>
<li>Nilvadipine</li>
<li><a href="Nisoldipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nisoldipine" title="Nisoldipine">Nisoldipine</a></li>
<li>Norelgestromin</li>
<li><a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">Omeprazole</a></li>
<li><a href="Orlistat.htm" tppabs="https://ptable.com/wiki/compounds/A/Orlistat" title="Orlistat">Orlistat</a></li>
<li><a href="Oxatomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxatomide" title="Oxatomide">Oxatomide</a></li>
<li><a href="Paclitaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Paclitaxel" title="Paclitaxel">Paclitaxel</a></li>
<li><a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li>
<li><a href="Piperine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperine" title="Piperine">Piperine</a></li>
<li><a href="Plicamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Plicamycin" title="Plicamycin">Plicamycin</a></li>
<li><a href="Prednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisolone" title="Prednisolone">Prednisolone</a></li>
<li><a href="Pregnanediol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnanediol" title="Pregnanediol">Pregnanediol</a></li>
<li>Pregnanedione (5β-dihydroprogesterone)</li>
<li>Pregnanolone</li>
<li><a href="Pregnenolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li>Pregnenolone 16α-carbonitrile</li>
<li>Proadifen</li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li>Quingestrone</li>
<li><a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">Reserpine</a></li>
<li>Reverse triiodothyronine</li>
<li><a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">Rifampicin</a></li>
<li><a href="Rifaximin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifaximin" title="Rifaximin">Rifaximin</a></li>
<li><a href="Rimexolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimexolone" title="Rimexolone">Rimexolone</a></li>
<li>Riodipine</li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir</a></li>
<li><a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">Simvastatin</a></li>
<li><a href="Sirolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Sirolimus" title="Sirolimus">Sirolimus</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spiroxatrine</li>
<li><span class="new">SR-12813</span></li>
<li><span class="new">Suberoylanilide</span></li>
<li>Sulfisoxazole</li>
<li><a href="Suramin.htm" tppabs="https://ptable.com/wiki/compounds/A/Suramin" title="Suramin">Suramin</a></li>
<li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li>
<li><span class="new">Tenylidone</span></li>
<li><a href="Terconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Terconazole" title="Terconazole">Terconazole</a></li>
<li>Testosterone isocaproate</li>
<li><a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">Tetracycline</a></li>
<li>Thiamylal sodium</li>
<li><a href="Thiothixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiothixene" title="Thiothixene" class="mw-redirect">Thiothixene</a></li>
<li>Thonzonium bromide</li>
<li>Tianeptine</li>
<li><a href="Troglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Troglitazone" title="Troglitazone">Troglitazone</a></li>
<li><a href="Troleandomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Troleandomycin" title="Troleandomycin">Troleandomycin</a></li>
<li><span class="new">Tropanyl 3,5-dimethulbenzoate</span></li>
<li><a href="Zafirlukast.htm" tppabs="https://ptable.com/wiki/compounds/A/Zafirlukast" title="Zafirlukast">Zafirlukast</a></li>
<li><a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">Zeranol</a></li></ul>

<ul><li><i>Antagonists:</i> <a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Sesamin.htm" tppabs="https://ptable.com/wiki/compounds/A/Sesamin" title="Sesamin">Sesamin</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i>Receptor/signaling modulators</i></dd></dl>
</div></td></tr></tbody></table></div><span>
</span>









<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-06-19" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Troglitazone&oldid=963447983  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Troglitazone&oldid=963447983'" tppabs="https://en.wikipedia.org/wiki/?title=Troglitazone&oldid=963447983">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>